A Clinical Trial to Determine the Safety and Efficacy of an Origin Satiety Complex on Self-report… (NCT07390266) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
A Clinical Trial to Determine the Safety and Efficacy of an Origin Satiety Complex on Self-reported Hunger and Satiety in Healthy Adults
Canada30 participantsStarted 2026-03
Plain-language summary
The goal of this clinical trial is to the safety and efficacy of the investigational product (IP), Origin Satiety Complex, on hunger and satiety in healthy adults. The main question it aims to answer is what is the difference in the net incremental area under the curve (niAUC) for self-reported postprandial hunger and satiety (T = 0 - T = 10.5 h), as assessed by satiety and hunger items of the Eating Behavior Visual Analog Scales (VAS), between the IP and placebo.
Who can participate
Age range21 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Males \& females 21 - 50 years of age, inclusive
✓. BMI between 18.5 - 29.9 kg/m²
✓. Females not of child-bearing potential, defined as those who have undergone a sterilization procedure (e.g. hysterectomy, bilateral oophorectomy, bilateral tubal ligation, complete endometrial ablation) or have been post-menopausal for at least 1 year prior to screening Or,
✓. Willingness to complete questionnaires, records, and diaries associated with the study and to complete all clinic visits
✓. Agrees to maintain current lifestyle habits (diet, physical activity, medications, supplements, and sleep) as much as possible throughout the study
✓. Agrees to consume the standardized dinner the night prior to study visits and comply with fasting requirements
✓. Agrees to avoid alcohol consumption in the 24 hours prior to clinic visits and caffeine consumption and physical exercise on the morning of each study visit
✓. Provided voluntary, written, informed consent to participate in the study
Exclusion criteria
✕. Individuals who are pregnant, breast feeding, or planning to become pregnant during the study
✕. Allergy, sensitivity, intolerance, or dietary restriction preventing consumption of investigational product, placebo, or standardized meal ingredients
✕. Poor venous access as assessed by the QI
What they're measuring
1
The difference in the net incremental area under the curve (niAUC) for self-reported postprandial hunger and satiety